|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Vaxxinity (NASDAQ: VAXX) through any online brokerage.
The latest price target for Vaxxinity (NASDAQ: VAXX) was reported by Jefferies on December 7, 2021. The analyst firm set a price target for 18.00 expecting VAXX to rise to within 12 months (a possible 120.59% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Vaxxinity (NASDAQ: VAXX) is $8.16 last updated Fri Jan 21 2022 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Vaxxinity.
Vaxxinity’s $Q4 earnings are confirmed for after-market on February 19, 2022.
There is no upcoming split for Vaxxinity.
Vaxxinity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.